Security key
92337R101
Vera Therapeutics, Inc. - Class A Common Stock, par value $0.001 per share (VERA)
CUSIP: 92337R101
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / Class A Common Stock, par value $0.001 per share
- Shares outstanding
- 72,325,000
- Total 13F shares
- 53,519,938
- Share change
- -420,815
- Total reported value
- $2,365,061,400
- Put/Call ratio
- 116%
- Price per share
- $44.20
- Number of holders
- 172
- Value change
- -$1,769,076
- Number of buys
- 92
- Number of sells
- 74
Report period
Q3 2024
Institutions
172
Top holders
10
VERA full security history
Newer quarter: Q4 2024
Previous quarter: Q2 2024
Vera Therapeutics, Inc. SEC filings
Vera Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 92337R101
Recent filing periods:
Top shareholders of VERA - Vera Therapeutics, Inc. - Class A Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Avoro Capital Advisors LLC |
13F
|
Company |
6%
|
4,309,590
|
$155,920,966 | — | 30 Jun 2024 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
5%
|
3,620,135
|
$130,977,000 | — | 30 Jun 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
4.6%
|
3,337,672
|
$120,756,973 | — | 30 Jun 2024 | |
| FMR LLC |
13F
|
Company |
3.9%
|
2,801,938
|
$101,374,117 | — | 30 Jun 2024 | |
| Sofinnova Investments, Inc. |
13F
|
Company |
3.9%
|
2,793,987
|
$101,086,450 | — | 30 Jun 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.5%
|
2,524,176
|
$91,324,688 | — | 30 Jun 2024 | |
| Commodore Capital LP |
13F
3/4/5
|
Company · 10%+ Owner |
3.4%
|
2,475,000
|
$89,545,500 | — | 30 Jun 2024 | |
| STATE STREET CORP |
13F
|
Company |
3%
|
2,155,553
|
$77,987,908 | — | 30 Jun 2024 | |
| Eversept Partners, LP |
13F
|
Company |
2.8%
|
2,043,214
|
$73,923,483 | — | 30 Jun 2024 | |
| Holocene Advisors, LP |
13F
|
Company |
2.5%
|
1,796,077
|
$64,982,066 | — | 30 Jun 2024 | |
| Kynam Capital Management, LP |
13F
|
Company |
2.1%
|
1,543,669
|
$55,849,944 | — | 30 Jun 2024 | |
| SAMLYN CAPITAL, LLC |
13F
|
Company |
1.7%
|
1,231,911
|
$44,570,540 | — | 30 Jun 2024 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
1.5%
|
1,119,000
|
$40,485,420 | — | 30 Jun 2024 | |
| First Light Asset Management, LLC |
13F
|
Company |
1.4%
|
1,005,723
|
$36,387,058 | — | 30 Jun 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.4%
|
984,442
|
$35,624,594 | — | 30 Jun 2024 | |
| Logos Global Management LP |
13F
|
Company |
1.3%
|
950,000
|
$34,371,000 | — | 30 Jun 2024 | |
| Woodline Partners LP |
13F
|
Company |
1.3%
|
948,917
|
$34,331,817 | — | 30 Jun 2024 | |
| Artal Group S.A. |
13F
|
Company |
1.3%
|
915,974
|
$33,139,939 | — | 30 Jun 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.1%
|
784,568
|
$28,385,671 | — | 30 Jun 2024 | |
| READYSTATE ASSET MANAGEMENT LP |
13F
|
Company |
1.1%
|
772,675
|
$27,955,382 | — | 30 Jun 2024 | |
| Altium Capital Management LLC |
13F
|
Company |
0.99%
|
714,000
|
$25,832,520 | — | 30 Jun 2024 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.93%
|
675,872
|
$24,453,049 | — | 30 Jun 2024 | |
| Polar Capital Holdings Plc |
13F
|
Company |
0.93%
|
675,000
|
$24,421,500 | — | 30 Jun 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.88%
|
635,360
|
$22,987,325 | — | 30 Jun 2024 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
0.86%
|
623,649
|
$22,563,621 | — | 30 Jun 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.73%
|
524,578
|
$18,979,232 | — | 30 Jun 2024 | |
| Integral Health Asset Management, LLC |
13F
|
Company |
0.69%
|
500,000
|
$18,090,000 | — | 30 Jun 2024 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
0.61%
|
441,162
|
$15,961,241 | — | 30 Jun 2024 | |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.61%
|
440,839
|
$15,949,555 | — | 30 Jun 2024 | |
| SCHRODER INVESTMENT MANAGEMENT GROUP |
13F
|
Company |
0.6%
|
433,172
|
$15,672,163 | — | 30 Jun 2024 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.54%
|
387,380
|
$14,015,427 | — | 30 Jun 2024 | |
| Rock Springs Capital Management LP |
13F
|
Company |
0.53%
|
381,192
|
$13,791,527 | — | 30 Jun 2024 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
0.52%
|
375,000
|
$13,567,500 | — | 30 Jun 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.51%
|
370,685
|
$13,411,383 | — | 30 Jun 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.51%
|
365,519
|
$13,224,477 | — | 30 Jun 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.49%
|
351,088
|
$12,702,364 | — | 30 Jun 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.42%
|
305,438
|
$11,050,748 | — | 30 Jun 2024 | |
| LORD, ABBETT & CO. LLC |
13F
|
Company |
0.42%
|
301,817
|
$10,919,000 | — | 30 Jun 2024 | |
| S.c.a. Candriam |
13F
|
Individual |
0.41%
|
293,760
|
$10,627,741 | — | 30 Jun 2024 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.4%
|
290,000
|
$10,492,200 | — | 30 Jun 2024 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.4%
|
288,444
|
$10,435,901 | — | 30 Jun 2024 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.35%
|
255,133
|
$9,230,712 | — | 30 Jun 2024 | |
| AXA S.A. |
13F
|
Company |
0.34%
|
246,201
|
$8,907,552 | — | 30 Jun 2024 | |
| Alphabet Inc. |
13F
|
Company |
0.33%
|
241,264
|
$8,728,932 | — | 30 Jun 2024 | |
| Cutter Capital Management, LP |
13F
|
Company |
0.32%
|
230,000
|
$8,321,400 | — | 30 Jun 2024 | |
| First Turn Management, LLC |
13F
|
Company |
0.29%
|
212,944
|
$7,704,314 | — | 30 Jun 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.25%
|
179,912
|
$6,509,217 | — | 30 Jun 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.23%
|
165,322
|
$5,981,364 | — | 30 Jun 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.22%
|
157,481
|
$5,697,663 | — | 30 Jun 2024 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.21%
|
154,338
|
$5,583,949 | — | 30 Jun 2024 |
Institutional Holders of Vera Therapeutics, Inc. - Class A Common Stock, par value $0.001 per share (VERA) as of Q3 2024
As of 30 Sep 2024,
Vera Therapeutics, Inc. - Class A Common Stock, par value $0.001 per share (VERA) was held by
172 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
53,519,938 shares.
The largest 10 holders included
Avoro Capital Advisors LLC, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock, Inc., Sofinnova Investments, Inc., FMR LLC, VANGUARD GROUP INC, COMMODORE CAPITAL LP, Eversept Partners, LP, Holocene Advisors, LP, and STATE STREET CORP.
This page lists
172
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
169
Q3 2024 holders
172
Holder diff
3
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.